602 
Comparison of the Current Health Status and Selected Baseline Characteristics of Perinatally and Behaviorally HIV-infected Children and Adolescents, through 24 Years of Age in the US: The CDC LEGACY Cohort Study, 2006 to 2007
Kenneth Dominguez*1, B Bohannon1, J Milum2, and The CDC LEGACY Consortium
1CDC, Atlanta, GA, US and 2Ginn Group Inc, Atlanta, GA, US
Background: The Centers for Disease and Prevention (CDC)
instituted a new cohort study in HIV-infected subjects from birth through 24
years of age as of 2004 to describe clinical and psychosocial aspects of HIV
infection.
Methods: Using a population-proportional-to-size
sampling method, 22 hospital and clinic sites were selected. This observational
longitudinal cohort study is limited to HIV-infected subjects from birth to 25
years of age at enrollment in 7 U.S. states. We included subjects with ≥1
abstracted clinic visit during or after 2006 in this analysis.
Results: As of July 31, 2007, 1480 HIV-infected
(68.5%) of approximately 2160 eligible youth had been enrolled and met
inclusion criteria, including 791 (53.4%) females, 1021 (69%) non-Hispanic blacks,
and 343 (23.2%) Hispanics. Participants were nearly equally divided into 3 age
groups (years) <13 (34%), 12 to 18 (36%), and 19 to 25 (29%) and had an
overall median age of 14.8 years. Their mode of HIV transmission was classified
as perinatal (70.3%), behavioral (12.4%), and other (transfusion, transplant,
breastfeeding, sexual abuse) (17.3%); with respective median ages (years) of
13.2, 21.8, and 16.4. Most subjects (77%) were being treated with ART, mainly protease
inhibitor (PI) -based regimens (52.6%), however perinatal subjects were twice
as likely to be on ART as behavioral subjects (p <0.001). Overall, 32%
of subjects had an HIV viral load <400 copies/mL and 40% had a viral load
<400 to 100,000 copies/mL. While perinatal subjects were about twice as
likely to have a viral load <400 copies/mL and no immunosuppression as
behavioral subjects, they were also 1.5 times as likely to have severe
immunosuppression (p = 0.03) and 3.6 times as likely to have an
AIDS-defining condition during their last visit (p = 0.0006). Fewer than
10% of subjects had a viral load ≥100,000 copies/mL (range 7.2% to 9.7%).
Sex was discussed by health care providers with 65.5% of subjects ≥13
years of age; 23.1% of these subjects reported being sexually active in 2006 to
2007; behavioral subjects were 3 times as likely as perinatal subjects to be
sexually active (p <<0.01).

Conclusions: Most LEGACY subjects were ≥13
years of age, receiving ART (mainly PI-based HAART), and experiencing no or
moderate immunosuppression, viral loads <10,000 copies/mL, and a lack of AIDS-defining
conditions. A significant proportion of all subjects ≥13 years of age
reported being sexually active. Urgent follow-up is recommended to prevent
secondary HIV transmission from this population.
|